Skip to main content

Health Care Stock Winners and Losers: Eli Lilly

Eli Lilly launches its blood-thinner Efient in the U.K., and Procter & Gamble cuts jobs in Puerto Rico.

Updated from 2:49 p.m. EDT April 8

Widely held health care-related stocks were mostly up Wednesday amid a rally in the broader market.

Eli Lilly

(LLY)

shares rose 1.2% to $32.34 Wednesday afternoon after the company, along with

Daiichi Sankyo

, launched blood-thinner Efient in the U.K. Efient, or prasugrel, was

approved in February

by European officials to help prevent blood clots in heart patients with stents. It will compete with Plavix, sold by

Bristol-Myers Squibb

(BMY)

and

Sanofi-Aventis

(SNY)

. Bristol shares rose 1.6% to $20.41. Sanofi-Aventis shares rose 0.5% to $27.71.

Also on the plus side was

Merck

(MRK)

, shares of which rose 1.4% to $26.76.

Among the day's losers:

GlaxoSmithKline

(GSK)

shares fell 0.3% to $30.06.

Pfizer

(PFE)

shares fell 0.4% to $13.48 in choppy trading.

Procter & Gamble

(PG)

shares fell 0.7% to $48.47 after the company said it was cutting about 90 jobs at a plant in Puerto Rico that makes Olay skin care products and Vicks cold medicine.